105 related articles for article (PubMed ID: 8284832)
1. Nalmefene in the treatment of interstitial cystitis.
Stone NN
Urol Clin North Am; 1994 Feb; 21(1):101-6. PubMed ID: 8284832
[TBL] [Abstract][Full Text] [Related]
2. Duration of opioid antagonism by nalmefene and naloxone in the dog. A nonparametric pharmacodynamic comparison based on generalized cross-validated spline estimation.
Wilhelm JA; Veng-Pedersen P; Zakszewski TB; Osifchin E; Waters SJ
Int J Clin Pharmacol Ther; 1995 Oct; 33(10):540-5. PubMed ID: 8574503
[TBL] [Abstract][Full Text] [Related]
3. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
4. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis.
Bergasa NV; Schmitt JM; Talbot TL; Alling DW; Swain MG; Turner ML; Jenkins JB; Jones EA
Hepatology; 1998 Mar; 27(3):679-84. PubMed ID: 9500694
[TBL] [Abstract][Full Text] [Related]
5. A preliminary trial of nalmefene for the treatment of emotional numbing in combat veterans with post-traumatic stress disorder.
Glover H
Isr J Psychiatry Relat Sci; 1993; 30(4):255-63. PubMed ID: 8163362
[TBL] [Abstract][Full Text] [Related]
6. [Clinical observation of the effect of nalmefene in treatment of septic shock].
Wang HL; Yu KJ; Liu HT
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Jun; 22(6):351-3. PubMed ID: 20594468
[TBL] [Abstract][Full Text] [Related]
7. Nalmefene: a long-acting opioid antagonist. Clinical applications in emergency medicine.
Wang DS; Sternbach G; Varon J
J Emerg Med; 1998; 16(3):471-5. PubMed ID: 9610980
[TBL] [Abstract][Full Text] [Related]
8. Nalmefene for elective reversal of procedural sedation in children.
Chumpa A; Kaplan RL; Burns MM; Shannon MW
Am J Emerg Med; 2001 Nov; 19(7):545-8. PubMed ID: 11698998
[TBL] [Abstract][Full Text] [Related]
9. Use of a narcotic antagonist (nalmefene) to suppress self-mutilative behavior in a stallion.
Dodman NH; Shuster L; Court MH; Patel J
J Am Vet Med Assoc; 1988 Jun; 192(11):1585-6. PubMed ID: 3410777
[TBL] [Abstract][Full Text] [Related]
10. Implantable technology for long-term delivery of nalmefene for treatment of alcoholism.
Costantini LC; Kleppner SR; McDonough J; Azar MR; Patel R
Int J Pharm; 2004 Sep; 283(1-2):35-44. PubMed ID: 15363499
[TBL] [Abstract][Full Text] [Related]
11. The impact of nalmefene on side effects due to intrathecal morphine at cesarean section.
Pellegrini JE; Bailey SL; Graves J; Paice JA; Shott S; Faut-Callahan M
AANA J; 2001 Jun; 69(3):199-205. PubMed ID: 11759562
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pruritus with topically applied opiate receptor antagonist.
Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
[TBL] [Abstract][Full Text] [Related]
13. Naltrexone effects on short-term and long-term smoking cessation.
Covey LS; Glassman AH; Stetner F
J Addict Dis; 1999; 18(1):31-40. PubMed ID: 10234561
[TBL] [Abstract][Full Text] [Related]
14. The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats.
June HL; Grey C; Warren-Reese C; Durr LF; Ricks-Cord A; Johnson A; McCane S; Williams LS; Mason D; Cummings R; Lawrence A
Alcohol Clin Exp Res; 1998 Dec; 22(9):2174-85. PubMed ID: 9884166
[TBL] [Abstract][Full Text] [Related]
15. Use of narcotic antagonists to modify stereotypic self-licking, self-chewing, and scratching behavior in dogs.
Dodman NH; Shuster L; White SD; Court MH; Parker D; Dixon R
J Am Vet Med Assoc; 1988 Oct; 193(7):815-9. PubMed ID: 3192459
[TBL] [Abstract][Full Text] [Related]
16. Opioid antagonists in the treatment of impulse-control disorders.
Kim SW
J Clin Psychiatry; 1998 Apr; 59(4):159-64. PubMed ID: 9590665
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of intravenous nalmefene for emergency department patients with suspected narcotic overdose: a pilot study.
Kaplan JL; Marx JA
Ann Emerg Med; 1993 Feb; 22(2):187-90. PubMed ID: 8427429
[TBL] [Abstract][Full Text] [Related]
18. Trial watch: Nalmefene reduces alcohol use in phase III trial.
Nat Rev Drug Discov; 2011 Aug; 10(8):566. PubMed ID: 21804585
[No Abstract] [Full Text] [Related]
19. Protective effect of nalmefene and naloxone on the ischemically damaged small bowel.
Lopez J; Naujokat P; Xavier R; Walters W; Toledo-Pereyra LH
Transplant Proc; 1991 Oct; 23(5):2448-9. PubMed ID: 1926426
[No Abstract] [Full Text] [Related]
20. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels.
Foster J; Brewer C; Steele T
Addict Biol; 2003 Jun; 8(2):211-7. PubMed ID: 12850780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
